Breaking News Instant updates and real-time market news.

CHGG

Chegg

$29.30

-1.445 (-4.70%)

16:22
11/04/19
11/04
16:22
11/04/19
16:22

Chegg reports Q3 adjusted EPS 18c, consensus 8c

Reports Q3 revenue $94.2M, consensus $89.22M.

  • 04

    Nov

  • 13

    Nov

CHGG Chegg
$29.30

-1.445 (-4.70%)

08/13/19
WBLR
08/13/19
INITIATION
WBLR
William Blair starts Chegg, K12 with Outperform ratings
William Blair analyst Stephen Sheldon yesterday afternoon initiated coverage of Chegg (CHGG) and K12 (LRN) with Outperform ratings, and of 2U (TWOU) with a Market Perform rating. The analyst also assumed coverage of Instructure (INST) with a Market Perform rating following an analyst departure earlier this year. The amount spent annually on traditional education is large and growing, estimated to reach close to $1.5 trillion in the United States, Sheldon wrote in a research note. There are "numerous pain points" in the education industry, and solutions from education technology providers are helping alleviate some of these "highly complex" issues, adds the analyst. He believes that Chegg should be able to deliver at least 20% revenue growth over the next three years and that K12 can deliver mid-single-digit revenue growth over time. For 2U, Sheldon believes tge shares will be range-bound until the company provides clarity on its long-term model and "rebuilds trust."
09/09/19
JEFF
09/09/19
UPGRADE
Target $44
JEFF
Buy
Chegg upgraded to Buy from Hold at Jefferies
Jefferies analyst Brent Thill upgraded Chegg to Buy from Hold while lowering his price target for the shares to $44 from $46.
09/09/19
JEFF
09/09/19
UPGRADE
Target $44
JEFF
Buy
Chegg 'skating to where the puck is headed,' Jefferies says in upgrade
Jefferies analyst Brent Thill upgraded Chegg to Buy from Hold while lowering his price target for the shares to $44 from $46. The recent pullback in the shares represents a buying opportunity, Thill tells investors in a research note. The company, by creating a full service learning platform and expanding its addressable market with product updates and acquisitions, is "skating to where the puck is headed," says the analyst. He sees Chegg as a "consistent" 20%-plus growth story with expanding margins and a market leading position. Thill views the company as "one of the best fundamental stories in Smid cap Internet."
10/04/19
BMOC
10/04/19
NO CHANGE
Target $35
BMOC
Outperform
Chegg price target lowered to $35 from $49 at BMO Capital
BMO Capital analyst Jeffrey Silber lowered his price target on Chegg to $35, updating his model to reflect the company's recently announced $80M acquisition of Thinkful and the multiple contraction following the disclosure of the deal. The analyst notes that the company has acknowledged the initial adverse EBITDA impact from the acquisition but also keeps his Outperform rating on the stock, stating that Chegg "continues to invest in content and services" to attract more subscribers and increase its total addressable market.

TODAY'S FREE FLY STORIES

DESP

Despegar.com

$12.42

0.19 (1.55%)

07:44
12/06/19
12/06
07:44
12/06/19
07:44
Conference/Events
Despegar.com to host investor day »

Investor day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 10

    Dec

  • 17

    Dec

MAKSY

Marks & Spencer

$0.00

(0.00%)

07:41
12/06/19
12/06
07:41
12/06/19
07:41
Upgrade
Marks & Spencer rating change  »

Marks & Spencer…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OKTA

Okta

$119.18

-2.64 (-2.17%)

07:40
12/06/19
12/06
07:40
12/06/19
07:40
Recommendations
Okta analyst commentary  »

Okta results reaffirm…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Dec

ULTA

Ulta Beauty

$236.09

-3.27 (-1.37%)

07:39
12/06/19
12/06
07:39
12/06/19
07:39
Recommendations
Ulta Beauty analyst commentary  »

Ulta Beauty quarter…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Mar

SAGE

Sage Therapeutics

$60.11

-89.11 (-59.72%)

07:39
12/06/19
12/06
07:39
12/06/19
07:39
Recommendations
Sage Therapeutics analyst commentary  »

Raymond James does not…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NUAN

Nuance

$17.73

0.18 (1.03%)

07:38
12/06/19
12/06
07:38
12/06/19
07:38
Conference/Events
Nuance to host investor day »

Investor day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

COO

Cooper Companies

$313.10

1 (0.32%)

07:36
12/06/19
12/06
07:36
12/06/19
07:36
Recommendations
Cooper Companies analyst commentary  »

Cooper Companies price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 13

    Dec

SLG

SL Green Realty

$85.75

-0.08 (-0.09%)

07:35
12/06/19
12/06
07:35
12/06/19
07:35
Hot Stocks
SL Green Realty announces $500M increase to share repurchase program »

SL Green Realty announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

DLTR

Dollar Tree

$90.80

1.47 (1.65%)

, BUD

AB InBev

$78.61

-0.76 (-0.96%)

07:35
12/06/19
12/06
07:35
12/06/19
07:35
Options
Unusual call flow in option market yesterday »

Notable call activity was…

DLTR

Dollar Tree

$90.80

1.47 (1.65%)

BUD

AB InBev

$78.61

-0.76 (-0.96%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

07:35
12/06/19
12/06
07:35
12/06/19
07:35
General news
FX Update: A firmer yen and a rallying New Zealand dollar were the main shows »

FX Update: A firmer yen…

RST

Rosetta Stone

$15.23

0.09 (0.59%)

07:34
12/06/19
12/06
07:34
12/06/19
07:34
Initiation
Rosetta Stone initiated  »

Rosetta Stone initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 12

    Dec

SLG

SL Green Realty

$85.75

-0.08 (-0.09%)

07:34
12/06/19
12/06
07:34
12/06/19
07:34
Hot Stocks
SL Green Realty increases quarterly dividend 4.1% to 88.5c per share »

SL Green Realty reported…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

UNFI

United Natural Foods

$9.43

-0.35 (-3.58%)

07:33
12/06/19
12/06
07:33
12/06/19
07:33
Hot Stocks
United Natural Foods to sell 13 Shoppers Food & Pharmacy stores »

United Natural Foods…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 18

    Dec

EW

Edwards Lifesciences

$242.87

-3.41 (-1.38%)

07:33
12/06/19
12/06
07:33
12/06/19
07:33
Recommendations
Edwards Lifesciences analyst commentary  »

Edwards Lifesciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZM

Zoom Video

$69.73

-0.22 (-0.31%)

07:33
12/06/19
12/06
07:33
12/06/19
07:33
Recommendations
Zoom Video analyst commentary  »

Zoom Video price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Dec

ONTX

Onconova

$0.30

-0.0148 (-4.77%)

07:32
12/06/19
12/06
07:32
12/06/19
07:32
Hot Stocks
Onconova, Inceptua announce Pre-approval Access collaboration for rigosertib »

Onconova Therapeutics and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BHVN

Biohaven Pharmaceutical

$53.79

-0.235 (-0.44%)

07:32
12/06/19
12/06
07:32
12/06/19
07:32
Hot Stocks
Biohaven's troriluzole successfully advances past interim futility analysis »

Biohaven announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SAGE

Sage Therapeutics

$60.11

-89.11 (-59.72%)

07:30
12/06/19
12/06
07:30
12/06/19
07:30
Recommendations
Sage Therapeutics analyst commentary  »

Sage Therapeutics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRIS

Curis

$1.86

0.045 (2.48%)

07:29
12/06/19
12/06
07:29
12/06/19
07:29
Hot Stocks
Curis provides updated results from Phase 1 dose escalation study of CA-4948 »

Curis announced updated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

XNCR

Xencor

$40.63

0.05 (0.12%)

07:29
12/06/19
12/06
07:29
12/06/19
07:29
Conference/Events
Xencor to host analyst & investor meeting »

Analyst & Investor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 09

    Dec

MRVL

Marvell

$23.44

-0.48 (-2.01%)

07:27
12/06/19
12/06
07:27
12/06/19
07:27
Recommendations
Marvell analyst commentary  »

Marvell price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 06

    Jan

SON

Sonoco

$59.91

-0.04 (-0.07%)

07:25
12/06/19
12/06
07:25
12/06/19
07:25
Conference/Events
Sonoco to host investor meeting »

Investor meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 09

    Dec

  • 13

    Dec

RRC

Range Resources

$3.59

0.01 (0.28%)

07:23
12/06/19
12/06
07:23
12/06/19
07:23
Downgrade
Range Resources rating change  »

Range Resources…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MR

Montage Resources

$5.30

0.09 (1.73%)

07:22
12/06/19
12/06
07:22
12/06/19
07:22
Upgrade
Montage Resources rating change  »

Montage Resources…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

TGTX

TG Therapeutics

$7.68

-0.51 (-6.23%)

07:19
12/06/19
12/06
07:19
12/06/19
07:19
Conference/Events
TG Therapeutics to host investor & analyst meeting »

Investor & Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 09

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.